New compounds protect heart cells during and after attack
Washington: Using two different compounds they developed, scientists from the Florida campus of The Scripps Research Institute (TSRI) have been able to show in animal models that inhibiting a specific enzyme protects heart cells and surrounding tissue against serious damage from heart attacks.
The compounds also protect against additional injury from restored blood flow after an attack, a process known as reperfusion.
The study was led by Philip LoGrasso, a professor and senior scientific director of discovery biology at Scripps Florida.
A heart attack severely restricts blood supply, starving heart cells and surrounding tissue of oxygen, which can cause enormous damage in relatively little time-sometimes in just a few minutes.
Known as an ischemic cascade, this drop-off of oxygen results in a sudden crush of metabolic waste that damages cell membranes as well as the mitochondria, a part of the cell that generates chemical energy and is involved in cell growth and death.
Unfortunately, restoring blood flow adds significantly to the damage, a serious medical issue when it comes to treating major ischemic events such as heart attack and stroke. Reperfusion re-invigorates production of free radicals and reactive oxygen species that attack and damage cells, exacerbating inflammation, turning loose white blood cells to attack otherwise salvageable cells and maybe even inducing potentially fatal cardiac arrhythmias.
The new study found that inhibiting the enzyme, c-jun-N-terminal kinase (JNK), pronounced "junk," protected against ischemic/reperfusion injury in rats, reducing the total volume of tissue death by as much as 34 percent. It also significantly reduced levels of reactive oxygen species and mitochondrial dysfunction.
In earlier studies, TSRI scientists found that JNK migrates to the mitochondria upon oxidative stress. That migration, coupled with JNK activation, they found, is associated with a number of serious health issues, including liver damage, neuronal cell death, stroke and heart attack. The peptide and small molecule inhibitor (SR3306) developed by LoGrasso and his colleagues blocks those harmful effects, thereby reducing programmed cell death four-fold.
"This is the same story. These just happen to be heart cells, but we know that oxidative stress kills cells, and JNK inhibition protects against this stress. Blocking the translocation of JNK to the mitochondria is essential for stopping this killing cascade and may be an effective treatment for damage done to heart cells during an ischemic/ reperfusion event," said LoGrasso.
In addition, LoGrasso said, biomarkers that rise during a heart attack shrink in the presence of JNK inhibition, a clear indication that blocking JNK reduces the severity of the infarction.
The findings appeared in the latest print edition of The Journal of Biological Chemistry.
More from India
More from World
More from Sports
More from Entertaiment
- Why is Akhilesh Yadav encouraging dishonesty for votes?
- Is Akhilesh Yadav seeking votes based on development made by Modi govt?
- UP polls: Polling for fifth phase of Assembly elections today
- Report: Are mobile smartphones more unhygienic than toilet seats?
- UP polls: PM Modi addresses public rally in Mau
- Virender Sehwag's reply to Kargil martyr's daughter has taken the Internet by storm
- Ind vs Aus: Mohammed Azharuddin says Jayant Yadav and Ishant Sharma should be replaced in next Test
- Indian doctor rescued from ISIS recounts horror, says 'they forced me to watch videos, shot me thrice'
- Gurmehar Kaur reacts to Virender Sehwag's tweet, says she is heart broken!
- WATCH: MS Dhoni rips apart bowlers to smash brilliant 129-run knock in Vijay Hazare Trophy